Daniel Leif Ivansson

Title: The Innovations of Daniel Leif Ivansson

Introduction

Daniel Leif Ivansson is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of methods for cell line development. With a total of three patents to his name, Ivansson's work is focused on improving the production of therapeutic proteins.

Latest Patents

Ivansson's latest patents include a method for cell line development that is applicable to the production of any therapeutic protein using mammalian cell lines, specifically Chinese Hamster Ovary (CHO) cells. This innovative method combines site-directed integration (SDI) with expression construct components that enhance the post-transcriptional processing of the gene of interest (GOI). Additionally, it introduces a one-time pre-CLD host cell line selection workflow to generate a production-competent cell line, which can be utilized in multiple CLD efforts using SDI thereafter.

Career Highlights

Throughout his career, Ivansson has worked with prominent companies in the biotechnology sector, including Cytiva Sweden AB and GE Healthcare Bio-Sciences AB. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in cell line development.

Collaborations

Ivansson has collaborated with several professionals in his field, including Andreas Castan and Camilla Estmer Nilsson. These partnerships have further enriched his work and expanded the impact of his innovations.

Conclusion

Daniel Leif Ivansson is a distinguished inventor whose contributions to cell line development have the potential to revolutionize the production of therapeutic proteins. His innovative methods and collaborations highlight his commitment to advancing biotechnology.